PMID: 6479274Oct 1, 1984Paper

Interactions between guanabenz and clonidine in their cardiovascular effects in the rat

Experimental Neurology
B T Ong, S H Chan

Abstract

In Sprague-Dawley rats anesthetized with pentobarbital sodium (40 mg/kg, i.p.), guanabenz and clonidine exhibited mutually interactive effects on the cardiovascular system. Pretreatment with either antihypertensive agent (5 or 10 micrograms/kg, i.v.) significantly potentiated both the degree and duration of the initial elevation in arterial pressure and cardiac contractility promoted by the other compound (10 micrograms/kg, i.v.). On the other hand, discernible antagonization existed mutually for their delayed hypotensive, as well as negative inotropic and chronotropic actions. Furthermore, these circulatory changes displayed comparable trends under parallel drug interaction schemes, as revealed by correlation coefficient evaluations. It is possible that guanabenz and clonidine may share a common mechanism(s) in their cardiovascular actions.

Citations

Sep 1, 1987·Toxicology Letters·J J Buccafusco, R S Aronstam
Aug 1, 1987·Journal of Pharmacological Methods·S H Chan, B T Ong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.